Glass House Brands (GLAS) Buildings (2021 - 2024)

Glass House Brands' (GLAS) quarterly Buildings came in at $154.2 million in Q1 2024, up 7.67% on a QoQ basis from $143.2 million in Q4 2023.

Glass House Brands (GLAS) Buildings (2021 - 2024) Analysis & Trends

Glass House Brands (GLAS) has 4 years of Buildings data on file, last reported at $154.2 million in Q1 2024.

  • On a quarterly basis, Buildings changed N/A year-over-year to $154.2 million in Q1 2024; TTM through Mar 2024 was $154.2 million, a N/A change from a year earlier, with the FY2023 full-year figure at $143.2 million, changed N/A from the prior year.
  • Buildings for Q1 2024 stood at $154.2 million, up from $143.2 million in the prior quarter.
  • Over the last five years, Buildings for GLAS reached as high as $154.2 million in Q1 2024 and fell as low as $108.0 million in Q4 2021.
  • Historically, Buildings has averaged $128.4 million across 4 years, with a median of $125.6 million in 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 89.28 Bn 87.42 Bn -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn
10 Glass House Brands 873.84 Mn 845.91 Mn 10.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2024 154.19 Mn
Dec 31, 2023 143.21 Mn
Mar 31, 2022 108.02 Mn
Dec 31, 2021 108.02 Mn